APOA1 and metabolic syndrome: This disruption may lead to dyslipidemia, which is characterized by elevated triglycerides and low cholesterol levels, an elevated apolipoprotein B-to-apolipoprotein A1 ratio and an increase in low-density lipoprotein cholesterol [28, 29], and is associated with increased blood pressure [30].